載入...

Lorlatinib in ALK- and ROS1-positive NSCLC: the future has a start

Na minha lista:
書目詳細資料
發表在:Transl Lung Cancer Res
Main Authors: Facchinetti, Francesco, Friboulet, Luc
格式: Artigo
語言:Inglês
出版: AME Publishing Company 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943229/
https://ncbi.nlm.nih.gov/pubmed/29782561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2018.02.04
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!